awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36347314-E433A6A8-B73B-459C-8B75-109DE56593A0
Q36347314-E433A6A8-B73B-459C-8B75-109DE56593A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36347314-E433A6A8-B73B-459C-8B75-109DE56593A0
Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438).
P2860
Q36347314-E433A6A8-B73B-459C-8B75-109DE56593A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36347314-E433A6A8-B73B-459C-8B75-109DE56593A0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
37e50dd6145a2a1866ff4ae24a5f0176c464e851
P2860
The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy.